Literature DB >> 32305206

CKD Awareness Among US Adults by Future Risk of Kidney Failure.

Chi D Chu1, Charles E McCulloch2, Tanushree Banerjee3, Meda E Pavkov4, Nilka R Burrows4, Brenda W Gillespie5, Rajiv Saran6, Michael G Shlipak7, Neil R Powe8, Delphine S Tuot8.   

Abstract

RATIONALE &
OBJECTIVE: Persons with chronic kidney disease (CKD) are often unaware of their disease status. Efforts to improve CKD awareness may be most effective if focused on persons at highest risk for progression to kidney failure. STUDY
DESIGN: Serial cross-sectional surveys. SETTING & PARTICIPANTS: Nonpregnant adults (aged≥20 years) with CKD glomerular filtration rate categories 3-4 (G3-G4) who participated in the National Health and Nutrition Examination Survey from 1999 to 2016 (n = 3,713). PREDICTOR: 5-year kidney failure risk, estimated using the Kidney Failure Risk Equation. Predicted risk was categorized as minimal (<2%), low (2%-<5%), intermediate (5%-<15%), or high (≥15%). OUTCOME: CKD awareness, defined by answering "yes" to the question "Have you ever been told by a doctor or other health professional that you had weak or failing kidneys?" ANALYTICAL APPROACH: Prevalence of CKD awareness was estimated within each risk group using complex sample survey methods. Associations between Kidney Failure Risk Equation risk and CKD awareness were assessed using multivariable logistic regression. CKD awareness was compared with awareness of hypertension and diabetes during the same period.
RESULTS: In 2011 to 2016, unadjusted CKD awareness was 9.6%, 22.6%, 44.7%, and 49.0% in the minimal-, low-, intermediate-, and high-risk groups, respectively. In adjusted analyses, these proportions did not change over time. Awareness of CKD, including among the highest risk group, remains consistently below that of hypertension and diabetes and awareness of these conditions increased over time. LIMITATIONS: Imperfect sensitivity of the "weak or failing kidneys" question for ascertaining CKD awareness.
CONCLUSIONS: Among adults with CKD G3-G4 who have 5-year estimated risks for kidney failure of 5%-<15% and≥15%, approximately half were unaware of their kidney disease, a gap that has persisted nearly 2 decades.
Copyright © 2020 National Kidney Foundation, Inc. All rights reserved.

Entities:  

Keywords:  CKD awareness; Chronic kidney disease (CKD); albuminuria; disease management; estimated glomerular filtration rate (eGFR); health literacy; kidney failure prevention; nationally representative survey; patient empowerment; public health; renal function; renal insufficiency; self-care; urinary albumin-creatinine ratio (UACR)

Mesh:

Year:  2020        PMID: 32305206      PMCID: PMC7387135          DOI: 10.1053/j.ajkd.2020.01.007

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  36 in total

1.  Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?

Authors:  Delphine S Tuot; Laura C Plantinga; Chi-yuan Hsu; Neil R Powe
Journal:  Am J Nephrol       Date:  2012-01-27       Impact factor: 3.754

2.  Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis.

Authors:  Navdeep Tangri; Morgan E Grams; Andrew S Levey; Josef Coresh; Lawrence J Appel; Brad C Astor; Gabriel Chodick; Allan J Collins; Ognjenka Djurdjev; C Raina Elley; Marie Evans; Amit X Garg; Stein I Hallan; Lesley A Inker; Sadayoshi Ito; Sun Ha Jee; Csaba P Kovesdy; Florian Kronenberg; Hiddo J Lambers Heerspink; Angharad Marks; Girish N Nadkarni; Sankar D Navaneethan; Robert G Nelson; Stephanie Titze; Mark J Sarnak; Benedicte Stengel; Mark Woodward; Kunitoshi Iseki
Journal:  JAMA       Date:  2016-01-12       Impact factor: 56.272

3.  How ready is general practice to improve quality in chronic kidney disease? A diagnostic analysis.

Authors:  Iain Crinson; Hugh Gallagher; Nicola Thomas; Simon de Lusignan
Journal:  Br J Gen Pract       Date:  2010-06       Impact factor: 5.386

4.  A predictive model for progression of chronic kidney disease to kidney failure.

Authors:  Navdeep Tangri; Lesley A Stevens; John Griffith; Hocine Tighiouart; Ognjenka Djurdjev; David Naimark; Adeera Levin; Andrew S Levey
Journal:  JAMA       Date:  2011-04-11       Impact factor: 56.272

5.  Pro: Risk scores for chronic kidney disease progression are robust, powerful and ready for implementation.

Authors:  Navdeep Tangri; Thomas Ferguson; Paul Komenda
Journal:  Nephrol Dial Transplant       Date:  2017-05-01       Impact factor: 5.992

6.  Understanding the management of early-stage chronic kidney disease in primary care: a qualitative study.

Authors:  Tom Blakeman; Joanne Protheroe; Carolyn Chew-Graham; Anne Rogers; Anne Kennedy
Journal:  Br J Gen Pract       Date:  2012-04       Impact factor: 5.386

7.  Treatment needs and diagnosis awareness in primary care patients with chronic kidney disease.

Authors:  Natasha J McIntyre; Richard Fluck; Chris McIntyre; Maarten Taal
Journal:  Br J Gen Pract       Date:  2012-04       Impact factor: 5.386

8.  Variation in Patients' Awareness of CKD according to How They Are Asked.

Authors:  Delphine S Tuot; Yunnuo Zhu; Alexandra Velasquez; Juan Espinoza; C Damaris Mendez; Tanushree Banerjee; Chi-Yuan Hsu; Neil R Powe
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

9.  Healthy behaviors, risk factor control and awareness of chronic kidney disease.

Authors:  Delphine S Tuot; Laura C Plantinga; Suzanne E Judd; Paul Muntner; Chi-Yuan Hsu; David G Warnock; Orlando M Gutiérrez; Monika Safford; Neil R Powe; William M McClellan
Journal:  Am J Nephrol       Date:  2013-01-31       Impact factor: 3.754

10.  Patient and provider experience and perspectives of a risk-based approach to multidisciplinary chronic kidney disease care: a mixed methods study.

Authors:  Michelle D Smekal; Helen Tam-Tham; Juli Finlay; Maoliosa Donald; Chandra Thomas; Robert G Weaver; Robert R Quinn; Kin Tam; Braden J Manns; Marcello Tonelli; Aminu Bello; Navdeep Tangri; Brenda R Hemmelgarn
Journal:  BMC Nephrol       Date:  2019-03-29       Impact factor: 2.388

View more
  16 in total

1.  Development and Validation of Prediction Models of Adverse Kidney Outcomes in the Population With and Without Diabetes.

Authors:  Morgan E Grams; Nigel J Brunskill; Shoshana H Ballew; Yingying Sang; Josef Coresh; Kunihiro Matsushita; Aditya Surapaneni; Samira Bell; Juan J Carrero; Gabriel Chodick; Marie Evans; Hiddo J L Heerspink; Lesley A Inker; Kunitoshi Iseki; Philip A Kalra; H Lester Kirchner; Brian J Lee; Adeera Levin; Rupert W Major; James Medcalf; Girish N Nadkarni; David M J Naimark; Ana C Ricardo; Simon Sawhney; Manish M Sood; Natalie Staplin; Nikita Stempniewicz; Benedicte Stengel; Keiichi Sumida; Jamie P Traynor; Jan van den Brand; Chi-Pang Wen; Mark Woodward; Jae Won Yang; Angela Yee-Moon Wang; Navdeep Tangri; John Chalmers; Mark Woodward; Chi-Yuan Hsu; Ana C Ricardo; Amanda Anderson; Panduranga Rao; Harold Feldman; Alex R Chang; Kevin Ho; Jamie Green; H Lester Kirchner; Samira Bell; Moneeza Siddiqui; Colin Palmer; Varda Shalev; Gabriel Chodick; Benedicte Stengel; Marie Metzger; Martin Flamant; Pascal Houillier; Jean-Philippe Haymann; Nikita Stempniewicz; John Cuddeback; Elizabeth Ciemins; Csaba P Kovesdy; Keiichi Sumida; Juan J Carrero; Marco Trevisan; Carl Gustaf Elinder; Björn Wettermark; Philip Kalra; Rajkumar Chinnadurai; James Tollitt; Darren Green; Josef Coresh; Shoshana H Ballew; Alex R Chang; Ron T Gansevoort; Morgan E Grams; Orlando Gutierrez; Tsuneo Konta; Anna Köttgen; Andrew S Levey; Kunihiro Matsushita; Kevan Polkinghorne; Elke Schäffner; Mark Woodward; Luxia Zhang; Shoshana H Ballew; Jingsha Chen; Josef Coresh; Morgan E Grams; Kunihiro Matsushita; Yingying Sang; Aditya Surapaneni; Mark Woodward
Journal:  Diabetes Care       Date:  2022-09-01       Impact factor: 17.152

2.  A Call for Implementation Science: Achieving Equitable Access to SGLT2 Inhibitors.

Authors:  Sophie E Claudel; Insa M Schmidt; Ashish Verma
Journal:  Kidney360       Date:  2022-03-02

3.  Patient Awareness of CKD: A Systematic Review and Meta-analysis of Patient-Oriented Questions and Study Setting.

Authors:  Chi D Chu; Michael H Chen; Charles E McCulloch; Neil R Powe; Michelle M Estrella; Michael G Shlipak; Delphine S Tuot
Journal:  Kidney Med       Date:  2021-06-01

Review 4.  Optimal Early Diagnosis and Monitoring of Diabetic Kidney Disease in Type 2 Diabetes Mellitus: Addressing the Barriers to Albuminuria Testing.

Authors:  Elena A Christofides; Niraj Desai
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec

5.  Nephrologist Performance in the Merit-Based Incentive Payment System.

Authors:  Sri Lekha Tummalapalli; Mallika L Mendu; Sarah A Struthers; David L White; Scott D Bieber; Daniel E Weiner; Said A Ibrahim
Journal:  Kidney Med       Date:  2021-07-21

Review 6.  COVID-19 Survival and its impact on chronic kidney disease.

Authors:  Joshua D Long; Ian Strohbehn; Rani Sawtell; Roby Bhattacharyya; Meghan E Sise
Journal:  Transl Res       Date:  2021-11-10       Impact factor: 7.012

7.  High Unawareness of Chronic Kidney Disease in Germany.

Authors:  Susanne Stolpe; Bernd Kowall; Christian Scholz; Andreas Stang; Cornelia Blume
Journal:  Int J Environ Res Public Health       Date:  2021-11-09       Impact factor: 3.390

Review 8.  Transforming the Care of Patients with Diabetic Kidney Disease.

Authors:  Frank C Brosius; David Cherney; Patrick O Gee; Raymond C Harris; Alan S Kliger; Katherine R Tuttle; Susan E Quaggin
Journal:  Clin J Am Soc Nephrol       Date:  2021-06-08       Impact factor: 10.614

9.  Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018.

Authors:  Sebastian Hödlmoser; Wolfgang C Winkelmayer; Jarcy Zee; Roberto Pecoits-Filho; Ronald L Pisoni; Friedrich K Port; Bruce M Robinson; Robin Ristl; Simon Krenn; Amelie Kurnikowski; Michał Lewandowski; Allison Ton; Juan Jesus Carrero; Eva S Schernhammer; Manfred Hecking
Journal:  PLoS One       Date:  2020-12-18       Impact factor: 3.752

10.  Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database.

Authors:  David Alfego; Jennifer Ennis; Barbara Gillespie; Mary Jane Lewis; Elizabeth Montgomery; Silvia Ferrè; Joseph A Vassalotti; Stanley Letovsky
Journal:  Diabetes Care       Date:  2021-08-05       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.